CareDx (CDNA) Sɔɔtɔ Fɔrɛkɛst
CareDx
AI forecast: CDNA
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
CareDx develops molecular tests for assessing the immune system and treating kidney and heart diseases. The company specializes in transplantation, offering tests to evaluate donor-recipient compatibility for organ transplants, monitor graft status, and detect signs of rejection. CareDx also develops diagnostic tests for cardiomyopathies and hereditary diseases. The company collaborates with clinics worldwide.
